ADGM (Adagio Medical Holdings) Forward PE Ratio: 0.00 (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADGM Adagio Medical Holdings Inc ADGM
11 GF Score
Price $0.71
! 3 Warning Signs
View Full Analysis

What is Adagio Medical Holdings Forward PE Ratio?

Adagio Medical Holdings ADGM -2.07% 11 Forward PE Ratio is 0.00 as of Aug. 06, 2026. GuruFocus rates ADGM with a GF Score™ of 11/100. The stock has 3 warning signs investors should review. Among 391 Medical Devices & Instruments companies, Adagio Medical Holdings ranks worse than 255754.22% on this metric.

Adagio Medical Holdings's Forward PE Ratio for today is 0.00.

Adagio Medical Holdings's PE Ratio without NRI for today is 0.00.

Adagio Medical Holdings's PE Ratio (TTM) for today is 0.00.


Adagio Medical Holdings  (NAS:ADGM) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Adagio Medical Holdings Forward PE Ratio Related Terms


Adagio Medical Holdings Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Adagio Medical Holdings's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adagio Medical Holdings Forward PE Ratio Chart

Adagio Medical Holdings Annual Data
Trend
Forward PE Ratio

Adagio Medical Holdings Quarterly Data
Forward PE Ratio

ADGM vs NXL, ICCM, ALRTF: Forward PE Ratio Comparison

For the Medical Devices subindustry, Adagio Medical Holdings's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adagio Medical Holdings Forward PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adagio Medical Holdings's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Adagio Medical Holdings's Forward PE Ratio falls into.


ADGM
11GF Score
Adagio Medical Holdings Inc ADGM
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adagio Medical Holdings Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
Adagio Medical Holdings (ADGM) has a Forward PE Ratio of 0.00 as of Aug. 06, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Adagio Medical Holdings and its competitors. According to the industry distribution chart, Adagio Medical Holdings ranks #999999 out of 391 companies in the Medical Devices & Instruments industry.
Is Adagio Medical Holdings' Forward PE Ratio too high?
Adagio Medical Holdings' current Forward PE Ratio is 0.00. Based on the distribution chart, Adagio Medical Holdings ranks #999999 out of 391 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Adagio Medical Holdings has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Adagio Medical Holdings' Forward PE Ratio compare to NXL and ICCM?
According to the Medical Devices & Instruments industry distribution chart, Adagio Medical Holdings ranks #999999 out of 391 companies for Forward PE Ratio. This places Adagio Medical Holdings in the lower half of its industry. The industry median Forward PE Ratio is 19.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Devices & Instruments company?
The median Forward PE Ratio among Medical Devices & Instruments companies is 19.63, based on 391 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Adagio Medical Holdings and its competitors. For the Medical Devices & Instruments industry, the median Forward PE Ratio is 19.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adagio Medical Holdings's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adagio Medical Holdings stock overvalued right now?
Adagio Medical Holdings (ADGM) has a current Forward PE Ratio of 0.00. The current Forward PE Ratio is 0.00. Adagio Medical Holdings' overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Adagio Medical Holdings (ADGM), the current Forward PE Ratio is 0.00 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adagio Medical Holdings Business Description

Address 26051 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
11GF Score

Get the complete analysis for ADGM

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.71
Price